We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
4 Stocks Trading Near 52-Week High With Room to Rise Further
Read MoreHide Full Article
Key Takeaways
Four momentum stocks near their 52-week high show potential for continued upside.
PEB, WWW, ECPG and ZIM demonstrate strong earnings growth and positive price momentum.
The screening criteria target stocks trading within 20% of their highs with undervalued metrics.
Stocks hitting their 52-week high and delivering consistent performance offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived to be winners. However, stocks touching a new 52-week high are often predisposed to profit-taking, resulting in pullbacks and trend reversals.
Given the high price, investors often wonder if the stock is overpriced. While the speculations are not absolutely baseless, all stocks hitting a 52-week high are not necessarily overpriced.
Investors might lose out on top gainers in an attempt to avoid the steep prices.
Stocks such as Pebblebrook Hotel Trust (PEB - Free Report) , Wolverine World Wide (WWW - Free Report) , Encore Capital Group (ECPG - Free Report) and ZIM Integrated Shipping Services (ZIM - Free Report) are expected to maintain their momentum and keep scaling new highs. Extensive information on a stock is necessary to understand whether or not there is scope for upside.
Here, we discuss a strategy to find the right stocks. The strategy borrows from the basics of momentum investing. This technique bets on “buy high, sell higher.”
52-Week High: A Good Indicator
Many times, stocks that hit a 52-week high fail to scale higher despite having potential. This is because investors fear that the stocks are overvalued and expect the price to crash.
Overvaluation is natural for most of these stocks as investors’ focus (or willingness to pay a premium) has helped them reach the level. But that does not always indicate an impending decline. Factors such as robust sales, surging profit levels, earnings growth prospects and strategic acquisitions that encourage investors to bet on these stocks could keep them motivated if there is no tangible negative. In other words, the momentum might continue.
Also, when a string of positive developments dominates the market, investors find their underreaction unwarranted, even if there are no company-specific driving forces.
Setting the Right Filters
We ran a screen to zero in on 52-week high stocks (trading near the high level) that hold tremendous upside potential. The screen includes parameters to shortlist stocks with strong earnings growth expectations, sturdy value metrics and price momentum.
Moreover, the screen filters stocks that are relatively undervalued compared to their peers in terms of earnings as well as sales, ensuring the continuation of their rally for some time.
Current Price/52 Week High >= .11: This is the ratio between the current price and the highest price at which the stock has traded in the past 52 weeks. A value greater than 0.11 implies that the stock is trading within 20% of its 52-week high range.
% Change Price – 4 Weeks > 0: It ensures that the stock price has moved north over the past four weeks.
% Change Price – 12 Weeks > 0: This metric guarantees continued upward price momentum for the stock over the past three months as well.
Price/Sales <= XIndMed: The lower, the better.
P/E using F(1) Estimate <= XIndMed: This metric measures the amount an investor puts into a company to obtain one dollar of earnings. It narrows down the list of stocks to those that are undervalued compared to the industry.
1-Year EPS Growth F(1)/F(0) >= XIndMed: This helps choose stocks that have higher growth rates than the industry. This is a meaningful indicator, as decent earnings growth adds to investor optimism.
Zacks Rank <=1: No screening is complete without the Zacks Rank, which has proved its worth since its inception. It is a fundamental truth that stocks with a Zacks Rank #1 (Strong Buy) have always managed to brave adversities and beat the market average. You can see the complete list of today’s Zacks #1 Rank stocks here.
Current Price >= 8: This parameter will help screen stocks that are trading at $8 or higher.
Volume – 20 days (shares) >= 100000: The inclusion of this metric ensures that there is a substantial volume of shares, so trading is easier.
Here are our four picks out of the eight stocks, each carrying a Zacks Rank #1, that made it through the screen:
Pebblebrook Hotel Trust looks positioned for a constructive fourth quarter and 2027. Its fourth-quarter outlook calls for Same-Property RevPAR growth of 4% to 6% and adjusted FFO of 26 cents to 30 cents per share, reflecting firmer demand. The full-year adjusted FFO outlook of $1.88 to $1.92 per share was raised 17 cents at the midpoint. Balance sheet flexibility improved as net debt to EBITDA declined to 5.1x, and the $350 million convertible notes due December 2026 are fully funded, with no other maturities until 2028. The Oct. 8 sale of EBITDA-negative Hotel Zags for $10 million streamlines its portfolio, while lower capital spending should support free cash flow. Stronger San Diego and Boston convention calendars and Los Angeles’ Super Bowl add to 2027 tailwinds.
The Zacks Consensus Estimate for the company’s 2026 earnings has remained steady at $1.84 per share in the past 30 days. PEB’s earnings surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 20.7%.
Wolverine World Wide looks well positioned for the near term, backed by a raised 2026 outlook. Management now expects revenues of roughly $2-$2.01 billion, up from $1.98-$2 billion, and adjusted earnings of $1.95-$1.99 per share versus $1.55-$1.65 previously. Adjusted operating margin is guided to be about 11.8%, including roughly 170 basis points from tariff refunds. Financial flexibility supports brand investment, with no revolver borrowings outstanding and net debt of $399 million. Brand initiatives add momentum. Merrell announced a three-year storytelling partnership with Sundance Collab, funding six filmmakers at $20,000 each, and will debut as Official Footwear Partner of the 2027 Sundance Film Festival. Cat Footwear’s Swarovski collection, launched on Oct. 30 in the United States and 18 international markets, broadens premium reach.
The Zacks Consensus Estimate for the company’s 2026 earnings has moved north by 21.2% to $2 per share in the past 30 days. WWW surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 23.2%.
Encore Capital’s raised 2026 outlook anchors the near-term case. Management now targets global portfolio purchases of $1.5 billion to $1.55 billion, collections of $2.9 billion to $2.95 billion, and earnings of $15.5 to $16 per share, a rise exceeding 40%. Favorable U.S. purchasing conditions and robust portfolio supply enabled Midland Credit Management to steadily deploy capital with discipline, with $310 million purchased last quarter. Cabot’s $80 million of European purchases add meaningful geographic diversification. Estimated remaining collections of $10.45 billion, up 10% year over year, offer solid, durable cash-flow visibility. Continued share buybacks, trimming shares outstanding to roughly 20.9 million from 21.7 million at 2025 year-end, add per-share earnings leverage. Together, these drivers support a modestly positive near-term outlook.
The Zacks Consensus Estimate for the company’s 2026 earnings has increased by 19.2% to $16.10 per share in the past 30 days. ECPG’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters, while missing the same once, the average surprise being 31.1%.
ZIM Integrated Shipping Services entered the fourth quarter with improving visibility. Management has raised full-year 2026 guidance twice since October. It now targets adjusted EBITDA of $3.3 billion to $3.5 billion and adjusted EBIT of $2 billion to $2.2 billion. ZX3, a premium express service linking Shanghai and Xiamen to Los Angeles, starts in December, lifting ZIM’s expedited network to seven weekly departures from China and Vietnam. The new Falcon service also offers faster transit from China to Argentina and South Brazil. Financial flexibility is solid, with $3.36 billion in cash, only $70 million of financial debt and net leverage of 0.8x. A $2.01 per share dividend, to be paid out on Dec. 8, adds shareholder appeal. Together, these catalysts position ZIM to close 2026 on a firm footing.
The Zacks Consensus Estimate for the company’s 2026 earnings has remained steady at $8.86 per share in the past 30 days. ZIM surpassed the Zacks Consensus Estimate in tow of the trailing four quarters, while missing the same twice, with the average surprise being 129.1%.
Image: Shutterstock
4 Stocks Trading Near 52-Week High With Room to Rise Further
Key Takeaways
Stocks hitting their 52-week high and delivering consistent performance offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived to be winners. However, stocks touching a new 52-week high are often predisposed to profit-taking, resulting in pullbacks and trend reversals.
Given the high price, investors often wonder if the stock is overpriced. While the speculations are not absolutely baseless, all stocks hitting a 52-week high are not necessarily overpriced.
Investors might lose out on top gainers in an attempt to avoid the steep prices.
Stocks such as Pebblebrook Hotel Trust (PEB - Free Report) , Wolverine World Wide (WWW - Free Report) , Encore Capital Group (ECPG - Free Report) and ZIM Integrated Shipping Services (ZIM - Free Report) are expected to maintain their momentum and keep scaling new highs. Extensive information on a stock is necessary to understand whether or not there is scope for upside.
Here, we discuss a strategy to find the right stocks. The strategy borrows from the basics of momentum investing. This technique bets on “buy high, sell higher.”
52-Week High: A Good Indicator
Many times, stocks that hit a 52-week high fail to scale higher despite having potential. This is because investors fear that the stocks are overvalued and expect the price to crash.
Overvaluation is natural for most of these stocks as investors’ focus (or willingness to pay a premium) has helped them reach the level. But that does not always indicate an impending decline. Factors such as robust sales, surging profit levels, earnings growth prospects and strategic acquisitions that encourage investors to bet on these stocks could keep them motivated if there is no tangible negative. In other words, the momentum might continue.
Also, when a string of positive developments dominates the market, investors find their underreaction unwarranted, even if there are no company-specific driving forces.
Setting the Right Filters
We ran a screen to zero in on 52-week high stocks (trading near the high level) that hold tremendous upside potential. The screen includes parameters to shortlist stocks with strong earnings growth expectations, sturdy value metrics and price momentum.
Moreover, the screen filters stocks that are relatively undervalued compared to their peers in terms of earnings as well as sales, ensuring the continuation of their rally for some time.
Current Price/52 Week High >= .11: This is the ratio between the current price and the highest price at which the stock has traded in the past 52 weeks. A value greater than 0.11 implies that the stock is trading within 20% of its 52-week high range.
% Change Price – 4 Weeks > 0: It ensures that the stock price has moved north over the past four weeks.
% Change Price – 12 Weeks > 0: This metric guarantees continued upward price momentum for the stock over the past three months as well.
Price/Sales <= XIndMed: The lower, the better.
P/E using F(1) Estimate <= XIndMed: This metric measures the amount an investor puts into a company to obtain one dollar of earnings. It narrows down the list of stocks to those that are undervalued compared to the industry.
1-Year EPS Growth F(1)/F(0) >= XIndMed: This helps choose stocks that have higher growth rates than the industry. This is a meaningful indicator, as decent earnings growth adds to investor optimism.
Zacks Rank <=1: No screening is complete without the Zacks Rank, which has proved its worth since its inception. It is a fundamental truth that stocks with a Zacks Rank #1 (Strong Buy) have always managed to brave adversities and beat the market average. You can see the complete list of today’s Zacks #1 Rank stocks here.
Current Price >= 8: This parameter will help screen stocks that are trading at $8 or higher.
Volume – 20 days (shares) >= 100000: The inclusion of this metric ensures that there is a substantial volume of shares, so trading is easier.
Here are our four picks out of the eight stocks, each carrying a Zacks Rank #1, that made it through the screen:
Pebblebrook Hotel Trust looks positioned for a constructive fourth quarter and 2027. Its fourth-quarter outlook calls for Same-Property RevPAR growth of 4% to 6% and adjusted FFO of 26 cents to 30 cents per share, reflecting firmer demand. The full-year adjusted FFO outlook of $1.88 to $1.92 per share was raised 17 cents at the midpoint. Balance sheet flexibility improved as net debt to EBITDA declined to 5.1x, and the $350 million convertible notes due December 2026 are fully funded, with no other maturities until 2028. The Oct. 8 sale of EBITDA-negative Hotel Zags for $10 million streamlines its portfolio, while lower capital spending should support free cash flow. Stronger San Diego and Boston convention calendars and Los Angeles’ Super Bowl add to 2027 tailwinds.
The Zacks Consensus Estimate for the company’s 2026 earnings has remained steady at $1.84 per share in the past 30 days. PEB’s earnings surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 20.7%.
Wolverine World Wide looks well positioned for the near term, backed by a raised 2026 outlook. Management now expects revenues of roughly $2-$2.01 billion, up from $1.98-$2 billion, and adjusted earnings of $1.95-$1.99 per share versus $1.55-$1.65 previously. Adjusted operating margin is guided to be about 11.8%, including roughly 170 basis points from tariff refunds. Financial flexibility supports brand investment, with no revolver borrowings outstanding and net debt of $399 million. Brand initiatives add momentum. Merrell announced a three-year storytelling partnership with Sundance Collab, funding six filmmakers at $20,000 each, and will debut as Official Footwear Partner of the 2027 Sundance Film Festival. Cat Footwear’s Swarovski collection, launched on Oct. 30 in the United States and 18 international markets, broadens premium reach.
The Zacks Consensus Estimate for the company’s 2026 earnings has moved north by 21.2% to $2 per share in the past 30 days. WWW surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 23.2%.
Encore Capital’s raised 2026 outlook anchors the near-term case. Management now targets global portfolio purchases of $1.5 billion to $1.55 billion, collections of $2.9 billion to $2.95 billion, and earnings of $15.5 to $16 per share, a rise exceeding 40%. Favorable U.S. purchasing conditions and robust portfolio supply enabled Midland Credit Management to steadily deploy capital with discipline, with $310 million purchased last quarter. Cabot’s $80 million of European purchases add meaningful geographic diversification. Estimated remaining collections of $10.45 billion, up 10% year over year, offer solid, durable cash-flow visibility. Continued share buybacks, trimming shares outstanding to roughly 20.9 million from 21.7 million at 2025 year-end, add per-share earnings leverage. Together, these drivers support a modestly positive near-term outlook.
The Zacks Consensus Estimate for the company’s 2026 earnings has increased by 19.2% to $16.10 per share in the past 30 days. ECPG’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters, while missing the same once, the average surprise being 31.1%.
ZIM Integrated Shipping Services entered the fourth quarter with improving visibility. Management has raised full-year 2026 guidance twice since October. It now targets adjusted EBITDA of $3.3 billion to $3.5 billion and adjusted EBIT of $2 billion to $2.2 billion. ZX3, a premium express service linking Shanghai and Xiamen to Los Angeles, starts in December, lifting ZIM’s expedited network to seven weekly departures from China and Vietnam. The new Falcon service also offers faster transit from China to Argentina and South Brazil. Financial flexibility is solid, with $3.36 billion in cash, only $70 million of financial debt and net leverage of 0.8x. A $2.01 per share dividend, to be paid out on Dec. 8, adds shareholder appeal. Together, these catalysts position ZIM to close 2026 on a firm footing.
The Zacks Consensus Estimate for the company’s 2026 earnings has remained steady at $8.86 per share in the past 30 days. ZIM surpassed the Zacks Consensus Estimate in tow of the trailing four quarters, while missing the same twice, with the average surprise being 129.1%.